Literature DB >> 7779966

Evaluation of a blocking ELISA using monoclonal antibodies for the detection of porcine epidemic diarrhea virus and its antibodies.

A Carvajal1, I Lanza, R Diego, P Rubio, P Cármenes.   

Abstract

Two blocking enzyme-linked immunosorbent assays (ELISAs) involving the use of monoclonal antibodies (MAb) as capture and detecting agents and an indirect fluorescence test (IFT) were used for the detection of porcine epidemic diarrhea virus (PEDV) antigen or its antibodies. In the ELISA for viral antigen detection, the blocking step is accomplished by incubation of fecal samples, in duplicate wells, with PEDV-specific positive or negative serum, whereas in the ELISA for antibody detection the blocking step is accomplished by incubation of serum samples with a gut-origin virus suspension. All the methods developed were used to monitor an experimental infection in piglets with the CV-777 strain of PEDV and a natural PED outbreak in a swine fattening unit. The antigen-detection ELISA was able to detect PEDV shedding for a longer time than have previously described methods. The blocking ELISA for antibody detection was able to detect the serum antibody response sooner after PEDV infection than did IFT.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7779966     DOI: 10.1177/104063879500700109

Source DB:  PubMed          Journal:  J Vet Diagn Invest        ISSN: 1040-6387            Impact factor:   1.279


  30 in total

1.  Immunohistochemical detection of porcine epidemic diarrhea virus compared to other methods.

Authors:  F Guscetti; C Bernasconi; K Tobler; K Van Reeth; A Pospischil; M Ackermann
Journal:  Clin Diagn Lab Immunol       Date:  1998-05

2.  Development of an antigen capture enzyme-linked immunosorbent assay for virus detection based on porcine epidemic diarrhea virus monoclonal antibodies.

Authors:  Zanyu Wang; Yin Jiyuan; Chen Su; Qiao Xinyuan; Tang Lijie; Li Yijing
Journal:  Viral Immunol       Date:  2015-02-06       Impact factor: 2.257

Review 3.  Porcine epidemic diarrhea (PED) infection, diagnosis and vaccination: A mini review.

Authors:  Simranjeet Singh Sekhon; Phat-Loc Nguyen; Ji-Young Ahn; Kyeong-Ah Lee; Lyon Lee; Sang Yong Kim; Hobaek Yoon; Jihoo Park; Jung Ho Ko; Yang-Hoon Kim
Journal:  Toxicol Environ Health Sci       Date:  2017-01-04

4.  A Computationally Designed Serological Assay for Porcine Epidemic Diarrhea Virus.

Authors:  Yunfeng Song; Pankaj Singh; Eric Nelson; Sheela Ramamoorthy
Journal:  J Clin Microbiol       Date:  2016-05-25       Impact factor: 5.948

Review 5.  Porcine epidemic diarrhea virus: An emerging and re-emerging epizootic swine virus.

Authors:  Changhee Lee
Journal:  Virol J       Date:  2015-12-22       Impact factor: 4.099

6.  The Carboxy Terminal Region on Spike Protein of Porcine Epidemic Diarrhea Virus (PEDV) Is Important for Evaluating Neutralizing Activity.

Authors:  Ki-Jong Kang; Dong-Hwan Kim; Eui-Ju Hong; Hyun-Jin Shin
Journal:  Pathogens       Date:  2021-05-31

7.  Porcine epidemic diarrhea virus E protein causes endoplasmic reticulum stress and up-regulates interleukin-8 expression.

Authors:  Xingang Xu; Honglei Zhang; Qi Zhang; Jie Dong; Yabing Liang; Yong Huang; Hung-Jen Liu; Dewen Tong
Journal:  Virol J       Date:  2013-01-19       Impact factor: 4.099

8.  Development of an indirect ELISA, blocking ELISA, fluorescent microsphere immunoassay and fluorescent focus neutralization assay for serologic evaluation of exposure to North American strains of Porcine Epidemic Diarrhea Virus.

Authors:  Faten Okda; Xiaodong Liu; Aaron Singrey; Travis Clement; Julie Nelson; Jane Christopher-Hennings; Eric A Nelson; Steven Lawson
Journal:  BMC Vet Res       Date:  2015-08-01       Impact factor: 2.741

9.  Detection of immunoglobulin (Ig) A antibodies against porcine epidemic diarrhea virus (PEDV) in fecal and serum samples.

Authors:  Priscilla F Gerber; Tanja Opriessnig
Journal:  MethodsX       Date:  2015-10-13

10.  Virulence of current German PEDV strains in suckling pigs and investigation of protective effects of maternally derived antibodies.

Authors:  S Leidenberger; Ch Schröder; L Zani; A Auste; M Pinette; A Ambagala; V Nikolin; H de Smit; M Beer; S Blome
Journal:  Sci Rep       Date:  2017-09-07       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.